Baumer

Baumer R&D Expenses

The Research & Development Expenses of Baumer (BALM4.SA) as of Nov 15, 2026 is 6.14 M BRL. In the previous year, Research & Development Expenses was 5.67 M BRL — a change of 8.28% (higher).

R&D Expenses

6.14 MBRL

YoY

8.28%

Last updated:

Research & Development Expenses of Baumer is 2022 6.14 M BRL. Research & Development Expenses of Baumer was 2021 5.67 M BRL. It decreases by 8.28% higher compared to the previous year.

The Baumer R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2015
5.68 M BRL
Jan 1, 2016
7.08 M BRL
Jan 1, 2017
6.38 M BRL
Jan 1, 2018
4.63 M BRL
Jan 1, 2019
4.76 M BRL
Jan 1, 2020
4.39 M BRL
Jan 1, 2021
5.67 M BRL
Jan 1, 2022
6.14 M BRL
The Baumer R&D Expenses history
YEARR&D ExpensesYoY
6.14 MBRL+8.28%
5.67 MBRL+29.37%
4.39 MBRL-7.78%
4.76 MBRL+2.77%
4.63 MBRL-27.49%
6.38 MBRL-9.78%
7.08 MBRL+24.54%
5.68 MBRL-5.63%
6.02 MBRL—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Research & Development Expenses of Baumer is 6.14 M BRL in 2022.

Research & Development Expenses of Baumer changed from 5.67 M BRL to 6.14 M BRL, representing a 8.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Baumer since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's BRL is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Baumer historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Baumer

All Key Metrics — Baumer